RxDoctor Payments Data

Mandy Russell, APRN

Family · Adamsville, TNNPI 1235400532

Payments from drug & device makers

$972in general payments, 2019–2025

Across 57 payments — averaging $17.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$313
  • AbbVie$268
  • Otsuka America Pharmaceutical, Inc.$138
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$101
  • Pfizer$61
  • Lundbeck LLC$44
  • plus $48 from 2 others

What the payments were for

  • Food & beverage$972100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$972 in reported general payments places this provider in the 60th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$2,262
Medicare patients
45
Services billed
94

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide53$58,154
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$21,558
EliquisApixaban31$21,046
TrulicityDulaglutide21$20,033
MounjaroTirzepatide17$17,141
FarxigaDapagliflozin Propanediol21$16,470
Mesalamine13$4,881
SymbicortBudesonide/Formoterol Fumarate20$4,681
Breo ElliptaFluticasone/Vilanterol12$4,597
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate22$3,015
Levemir FlexpenInsulin Detemir19$2,899
Gabapentin115$2,233
Albuterol Sulfate HfaAlbuterol Sulfate93$2,188
Pantoprazole Sodium205$1,748
Atorvastatin Calcium231$1,684

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$34$58,15453 claims
GSKTrelegy Ellipta, Breo Ellipta$14$26,15541 claims
AstraZenecaFarxiga, Symbicort$313$21,15141 claims
PfizerEliquis$61$21,04631 claims
AbbVieSynthroid$268$1,61232 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 6,706 family providers in Tennessee.

Other family in Adamsville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →